Preciseplan 2 0
Precision Therapy Intl.
FDA Clearance Information
The preciseplan 2 0 was cleared through the FDA 510(k) pathway on September 20, 2002. Manufactured by Precision Therapy Intl., it is classified as a Class 2 device under product code MUJ.
What It Is
FDA-Cleared Indications
- The FDA record identifies PrecisePlan 2 0 under product code MUJ for a dialysis vascular-access-related use.
- The available FDA summary does not state the specific procedure, anatomy, or performance claims for the device.
Clinical Applications
- Use in the labeled clinical setting for dialysis vascular-access care, as specified in the manufacturer's complete 510(k) labeling.
- Use by appropriately trained clinicians only according to the device's instructions for use and compatible procedural equipment.
Practical Considerations
- The publicly available summary is insufficient to confirm whether this is an access device, planning system, guide, catheter, imaging accessory, or another device type.
- Confirm the complete FDA-cleared labeling and instructions for use before describing specific procedures, access sites, sizes, or compatible equipment.
- Do not assume MRI safety, sterilization method, single-use status, or durability from the 510(k) classification alone; verify these details in the manufacturer's labeling.
- Evaluate compatibility with the imaging system and other procedural equipment before use.
- Use only by clinicians trained in dialysis vascular-access procedures and device-specific handling.
Frequently Asked Questions
What is preciseplan 2 0 used for?
The preciseplan 2 0 is used for planning and executing dialysis access procedures, ensuring precise placement of vascular access points.
What specialties typically use this device?
Nephrologists and vascular surgeons typically use this device in hospital and dialysis center settings.
What are the FDA-cleared indications?
The device is indicated for use in patients requiring dialysis access, aiding in the precise planning and execution of vascular access procedures.